Supplementary Table S1 from PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia
收藏Figshare2026-01-12 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_S1_from_PKC_Inhibitor_MS-553_Displays_Preclinical_Efficacy_in_Both_Treatment-Na_ve_and_BTK_Inhibitor_Resistant_Chronic_Lymphocytic_Leukemia/31047012
下载链接
链接失效反馈官方服务：
资源简介：
Characteristics of CLL patients with dual-refractory disease
创建时间：
2026-01-12
